Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents
- PMID: 20110639
- DOI: 10.1159/000277762
Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents
Abstract
Background: Dermatophytes are the main cause of onychomycoses, but various non-dermatophyte filamentous fungi are often isolated from abnormal nails.
Objective: Our aim was the in situ identification of the fungal infectious agent in 8 cases of onychomycoses which could not be cured after systemic terbinafine and itraconazole treatment.
Methods: Fungal DNA was extracted from nail samples, and infectious fungi were identified by restriction fragment length polymorphism (RFLP) of amplified fungal ribosomal DNA using a previously described PCR/RFLP assay.
Results: PCR/RFLP identification of fungi in nails allows the identification of the infectious agent: Fusarium sp., Acremonium sp. and Aspergillus sp. were found as a sole infectious agent in 5, 2 and 1 cases, respectively.
Conclusions: Fusarium spp. and other non-dermatophyte filamentous fungi are especially difficult to cure in onychomycoses utilising standard treatment with terbinafine and itraconazole. PCR fungal identification helps demonstrate the presence of moulds in order to prescribe alternative antifungal treatments.
Similar articles
-
Evaluation of a polymerase chain reaction-restriction fragment length polymorphism assay for dermatophyte and nondermatophyte identification in onychomycosis.Br J Dermatol. 2009 Oct;161(4):791-6. doi: 10.1111/j.1365-2133.2009.09291.x. Epub 2009 May 5. Br J Dermatol. 2009. PMID: 19558597
-
[Diagnosis of non dermatophyte onychomycosis ant its relevance for treatment].Rev Med Suisse. 2013 Apr 3;9(380):730-3. Rev Med Suisse. 2013. PMID: 23621043 French.
-
Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.J Am Acad Dermatol. 2001 Mar;44(3):479-84. doi: 10.1067/mjd.2001.110874. J Am Acad Dermatol. 2001. PMID: 11209118 Clinical Trial.
-
Other fungi causing onychomycosis.Clin Dermatol. 2010 Mar 4;28(2):160-3. doi: 10.1016/j.clindermatol.2009.12.009. Clin Dermatol. 2010. PMID: 20347658 Review.
-
A case of onychomycosis due to Aspergillus sydowii diagnosed using DNA sequence analysis.Mycoses. 2008 Mar;51(2):170-3. doi: 10.1111/j.1439-0507.2007.01458.x. Mycoses. 2008. PMID: 18254756 Review.
Cited by
-
High Trichophyton violaceum-Induced Tinea Capitis with Isolation of Many Non-Dermatophyte Molds in Scalp Scrapings in Patients Referred to a Dermatology Clinic in Addis Ababa, Ethiopia.Clin Cosmet Investig Dermatol. 2022 Jul 11;15:1313-1324. doi: 10.2147/CCID.S367763. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 35847420 Free PMC article.
-
Simultaneous Delivery of Econazole, Terbinafine and Amorolfine with Improved Cutaneous Bioavailability: A Novel Micelle-Based Antifungal "Tri-Therapy".Pharmaceutics. 2022 Jan 24;14(2):271. doi: 10.3390/pharmaceutics14020271. Pharmaceutics. 2022. PMID: 35214004 Free PMC article.
-
Hydrophobic Interactions of Modified Coconut Oil and Pluronic 127 Enable Stable Formation of Bioactive Hydrogel for Onychomycosis.Gels. 2025 Jul 31;11(8):592. doi: 10.3390/gels11080592. Gels. 2025. PMID: 40868722 Free PMC article.
-
Combination of Photodynamic Therapy and Oral Antifungals for the Treatment of Onychomycosis.Pharmaceuticals (Basel). 2022 Jun 7;15(6):722. doi: 10.3390/ph15060722. Pharmaceuticals (Basel). 2022. PMID: 35745641 Free PMC article.
-
Prevalence and Risk Factors of Superficial Fungal Infection among Patients Attending a Tertiary Care Hospital in Central Nepal.Interdiscip Perspect Infect Dis. 2022 Oct 4;2022:3088681. doi: 10.1155/2022/3088681. eCollection 2022. Interdiscip Perspect Infect Dis. 2022. PMID: 36247346 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous